Article Details
Retrieved on: 2021-05-12 13:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The startup's proprietary fully human monoclonal antibody platform enables rapid discovery and optimization of broad and potent therapeutic molecules.
Article found on: news.vanderbilt.edu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here